Orbis Appoints Joanne Smith Farrell Chief Executive

Company Orbis Medicines Event Type Leadership appointment (CEO) Modality AI-designed oral macrocycles Asset Platform (candidates undisclosed) Target Immunology and inflammation targets Disease Area Immunology and inflammation Summary Orbis Medicines appointed Joanne Smith-Farrell CEO on 27 October. Co-founder and outgoing CEO Morten Graugaard moved to chief…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Curium Agrees to Acquire Lantheus for Up to $8 Billion
Typewriter Launches with $56 Million for All-RNA Gene Insertion
Ligand Funds AvenCell CAR T Pipeline
US Cooperative Group Will Test Ivonescimab in Biliary Cancer